Trial
NCT02845414
Study of CD133KDEL Toxin in the Treatment for Solid Tumors
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Solid Tumors
Intervention
CD133KDEL (dCD133KDEL)
Why stopped
Funding unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-03